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Age, blood pressure and smoking effects on chronic renal fail- Smoking has been related to the onset of microalbumi-
ure in primary glomerular nephropathies. nuria or proteinuria, as well as to chronic renal failure
Background. Smoking is a known risk factor for renal dam- (CRF), in several cohort studies of patients with diabe-
age in diabetic patients, but its relationship to other renal
tes, both type 1 [1] and type 2 [2–4]. Although otherdiseases is less clear. To assess its effect in primary glomerular
studies have reported negative results [5], smoking isnephropathy (GN), we used data from a case control study
now recognized as a risk factor for the progression ofdesigned to assess several environmental risk factors.
Methods. This study included 295 biopsy-proven GN cases, renal damage in diabetes patients [6]. Its role in other
80 membranous nephropathy, 116 IgA nephropathy, and 99 types of kidney disease has been studied less, with more
nephrotic syndrome with either minimal change nephropathy contradictory results. Two large case control studies didor focal segmental hyalinosis, and 242 matched hospital controls,
not observe any relationship between smoking and CRFwith diseases unrelated to smoking. Subjects were interviewed
from various nephropathies [7, 8]. On the other hand, aabout their smoking history. Chronic renal failure (CRF), de-
fined by serum creatinine .150 mmol/L, was present in 74 cohort study including 332,544 men found that heavy
cases (57 men and 17 women). Logistic regression was used to smoking ($20 cigarettes/day) was significantly associ-
estimate odds ratios (ORs) adjusted for age and social class. ated with an excess risk of end-stage renal failure (ESRF)
Results. In men, the percentage of ever-smokers did not (abstract; Welton et al, J Am Soc Nephrol 6:408a, 1995].differ between GN cases (60%) and controls [65%, OR 5 0.9
Another cohort of 11,912 hypertensive men provided no(95% Confidence Interval 0.6–1.4)], but was significantly higher
evidence of a dose-effect relationship between smokingamong cases with CRF (75%) than those without [55%, OR 5
2.4 (1.2–4.5)]. Dose-effect relationships were observed with and ESRF incidence [9]. For specific nondiabetic ne-
both the daily and cumulative dose; this relationship was phropathies, smoking has been associated with an accel-
stronger in the comparison of cases with CRF and those without erated decline in renal function among patients with
CRF than in the comparison of cases with CRF with controls:
lupus nephritis [10]. Likewise, a retrospective study ob-OR 5 1.9 versus 1.3 (#20 cigarettes/day) and OR 5 5.2 versus
served a strong dose-effect relationship between smok-3.0 (.20 cigarettes/day); OR 5 1.9 versus 1.4 (#15 pack years)
ing and the risk of ESRF among men with IgA nephropa-and OR 5 3.9 vs. 2.0 (.15 pack years). Interactions between
age, hypertension, and smoking were observed in the risk of thy (IgAN) or polycystic kidney disease (PKD) [11].
CRF: smoking was significantly related to CRF among cases These two studies suggest that smoking may be a risk
who were older than 40 years and/or hypertensive, but not factor for the progression of renal diseases not related
among those cases younger than 40 or normotensive. The re-
to diabetes.sults did not significantly differ among the three histologic
To assess whether smoking was a risk factor for pri-types. No relationship was shown between smoking and CRF
mary glomerular nephropathy (GN), we used data fromin women.
Conclusion. This study provides additional support for the a case control study designed to investigate several envi-
hypothesis that smoking is related to GN severity, particularly ronmental risk factors. Smoking was a strong secondary
in the at-risk groups of men older than 40 and/or hypertensive hypothesis of this study, which relationship with GN was
patients. These findings should be corroborated by further ob-
analyzed in detail according to sex, histologic type, andservations in other populations.
state of renal function.
Key words: hypertension, cigarettes, glomerulonephritis, chronic renal METHODSfailure, proteinuria, progressive renal disease.
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histologically examined by light and electron microscopy and smoking starting and stopping dates were recorded
in detail. To minimize bias, the interviewers were trainedand immunofluorescence. The three most frequent types
of GN were: membranous nephropathy (MN), nephrotic to read a standardized questionnaire with closed ques-
tions in the same conditions for cases and controls. Thesyndrome with either minimal change nephropathy or
focal segmental hyalinosis (MCN/FSH), and IgAN. The interview lasted 41 minutes on average in both groups.
The methods for assessing occupational exposures arestudy was limited to patients aged over 18. Those with
secondary GN were excluded. Of 375 cases identified, detailed elsewhere [14].
80 (33 MN, 9 MCN/FSH, 38 IgAN) were not available
Statistical analysisfor an interview: 3 had died, while 69 could not be traced,
and 8 refused to participate. These cases did not differ Smoking exposure was first studied as a dichotomous
variable, comparing ever-smokers, including ex-smokersfrom those who were included, except that nonincluded
MN patients were more likely to have CRF (24%) than and current smokers, with never-smokers. Dose-effect
relationships were then studied with the following fourthose included (7%). In all, 295 case patients were inter-
viewed: 80 with MN, 99 with MCN/FSH, and 116 with variables: (1) smoking status: never-smokers, ex-smokers,
current smokers; (2) lifetime average number of cigarettes/IgAN. Medical records provided the clinical data. Hyper-
tension (HT) was defined according to World Health day at 0, #20 cigarettes/day, and .20 cigarettes/day; (3)
duration of smoking at 0, #20 years, and .20 years; andOrganization criteria: systolic blood pressure $140 mm Hg
or diastolic blood pressure $90 mm Hg or current (4) cumulative quantity at 0, #15, and .15 pack-years
(PY; 1 PY 5 1 pack of 20 cigarettes/day 3 1 year).anti-HT therapy. CRF was defined as serum creatinine
.150 mmol/L. Thirteen subjects smoked pipes, cigarillos, or cigars,
for which quantities were converted into equivalent num-
Controls bers of cigarettes for dose estimates, following the meth-
ods used in the French survey mentioned previously inIn each hospital, control patients were selected in
five different departments and matched to cases for sex, this article [13]: 1 pipe or 1 cigarillo 5 2 cigarettes, 1 cigar 5
4 cigarettes, and 1 pack of tobacco 5 40 cigarettes.year of birth (65 years), geographic origin (France or
abroad), and place of residence (Paris area or province). Analyses were carried out separately for men and
women. Relationships between smoking and GN wereVery few controls (,10) refused to participate. Subjects
with a history of renal disease, proteinuria, bladder can- studied for GN as a whole and according to histologic
type and CRF (yes/no). For comparisons of all cases (orcer, or occupational disease were excluded. Diagnoses of
the control patients were cardiovascular diseases (31%); by histologic type) with controls, the potential duration
of exposure to tobacco was made comparable for casesurinary lithiasis (13%); nonmalignant urologic diseases
(11%); trauma (8%); ear, nose, and throat diseases (8%); and controls by truncating smoking history for each case
and his or her matched control at the age of the case’sinfectious diseases (5%); and assorted other disorders
including musculoskeletal, respiratory, digestive, and renal biopsy (“age at renal biopsy”); ex-smokers were
defined in this article as those who quit smoking beforenonmalignant skin diseases, minor psychiatric disorders,
and ill-defined symptoms (24%). “renal biopsy.” When cases with and without CRF were
compared with controls, the smoking history was trun-Controls with a smoking-related disease, that is, a re-
spiratory or ischemic cardiovascular disease, were ex- cated at the age of the case’s CRF for those with CRF
or interview for those without CRF (“age at CRF orcluded from this analysis. This method tends to improve
representativeness of hospital controls and to result in interview”); ex-smokers were defined in this article as
those who quit smoking before the truncating date.an exposure rate closer to that of the general population
[12]. As a matter of fact, the smoking pattern of the 242 Odds ratios (ORs) were estimated with BMDP (Bio-
medical Computer Program) logistic regression whenremaining controls was similar to that of the French
population, observed in a national survey [13]. Based on comparing cases with their matched controls and polyto-
mous regression when comparing cases with or withoutthis survey, the expected percentages of smokers ob-
tained by indirect standardization for age were 70 and CRF with all controls. The matching for year of birth
was rather imprecise (65 years) so that all ORs were34% among male and female controls, respectively; 65
and 37% were actually observed. adjusted for “age at renal biopsy” when comparing cases
with controls and “age at CRF or interview” when com-
Data collection paring cases according to their CRF status with controls.
ORs were also adjusted for social class defined by em-Information was recorded by interviewing subjects
about their personal characteristics, lifelong occupa- ployment status at interview. Subjects were classified
into four categories: managerial workers, clerical andtional exposures to organic solvents, silica and heavy
metals, smoking and alcohol habits, potential nephro- sales workers, production workers, and unemployed.
The Breslow-Day test for homogeneity was used to com-toxic drug intake, and medical history. Type, quantities,
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Table 1. Characteristics of cases and controls
Cases by histologic type Cases by CRF status
Controls All cases MCN/FSH MN IgAN No CRF CRF
(242) (295) (99) (80) (116) (220) (74)
Sociodemographic characteristics
Men/women N 150/92 190/105 54/45 47/33 89/27 132/88 57/17
Mean age6SD 41.2616.5 41.6616.7 41.6617.5 49.8616.4 36.0613.8 41.5617.6 42.4614.9
Social class
Managerial workers 18% 21% 21% 20% 22% 19% 27%
Clerical and sales workers 50% 46% 51% 53% 39% 50% 35%
Production workers 26% 26% 25% 21% 30% 25% 31%
Never employed 6% 6% 3% 6% 9% 6% 7%
Geographic origin
Metropolitan France 72% 72% 68% 83% 69% 74% 66%
West Indies 5% 5% 12% 2% 0% 4% 7%
Foreign country 23% 23% 22% 15% 31% 22% 27%
Clinical characteristics
Hypertension 14% 47% 45% 37% 57% 36% 84%
Hypertension before renal biopsy — 24% 15% 23% 32% 20% 36%
Chronic renal failure 0% 25% 25% 8% 37% — —
Abbreviations are: GN, glomerular nephropathy; CRF, chronic renal failure; IgAN, IgA nephropathy; MN, membranous nephropathy; MCN/HSF, minimal change
nephropathy or focal segmental hyalinosis.
pare the ORs of the three histologic types [15]. To com- Relationship between smoking and GN by sex and
histologic typepare our results with those of Orth et al [11], we also
compared cases with CRF with those without CRF, as Among men, the adjusted OR of all GN associated
a whole and by histologic type. Because of our study with smoking was close to one (Table 2). For women,
design, these two groups of cases were not matched as on the other hand, it was only 0.5 and almost statistically
they were in Orth’s study [11], but potential confounding significant.
by age was taken into account by adjusting for “age at The ORs for each sex did not differ significantly among
CRF or interview.” Since neither geographic origin nor the three histologic types, nor, with one exception, did
place of residence (Paris area or provinces) was related they differ significantly from one. The exception involved
to CRF, no adjustment was made for the two other women with IgAN, where the OR was well below one,
matching variables (Table 1). We also adjusted for social but the percentage of smokers among the matched con-
class because it is strongly related to smoking and had trols of these cases was much higher than in the other
a slightly different pattern in the two groups. The fit of two control groups.
all regression models was checked with the Hosmer and
Relationship between smoking and GN according toLemeshow goodness-of-fit test, as performed in the
renal functionBMDP LR procedure (1990).
For men, the percentage of smokers was significantly
higher among the overall cases with CRF than among
RESULTS those without CRF (Table 3). This was also the case
Cases and controls were comparable with respect to for IgAN and, although not to the point of statistical
matching variables: sex, age, geographic origin, and place significance, for MCN/FSH. For MN, all four cases with
of residence (Table 1). The mean age at renal biopsy CRF smoked. The adjusted ORs of the comparisons
was higher among MN than MCN/FSH or IgAN patients. between cases with CRF and controls were lower than
CRF was present in 25% of all cases, 30% among men, the ORs reported in the previously mentioned sentences,
and 16% among women. Hypertension before renal within each histologic subgroup and especially for IgAN,
biopsy or CRF was more frequent among IgAN patients a subgroup containing very few cases without CRF who
than among MCN/FSH and MN patients. Cases with and smoked.
without CRF did not significantly differ according to For women, the percentage of smokers did not differ
matching variables, with the exception of sex. Distribu- significantly between cases with and without CRF. The
tion of social class did not differ between cases and con- paucity of CRF cases did not allow any further analysis
trols or among the three histologic types, but did show of this subgroup.
a slightly different pattern, not statistically significant, For men, the OR for ex-smokers was significantly
higher than that for current smokers (Table 4). Note,according to CRF.
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Table 2. Relation between GN and smoking, by sex and histologic type
Men Women
Cases Controls ORa Cases Controls ORa
(N ) % (N ) % [95% CI] (N ) % (N ) % [95% CI]
All GN cases (190) (150) (105) (92)
Never-smokers 40% 35% 1 75% 63% 1
Ever-smokers 60% 65% 0.9 [0.6–1.4] 25% 37% 0.5 [0.3–1.0]b
IgAN (89) (69) (27) (21)
Never-smokers 49% 36% 1 81% 48% 1
Ever-smokers 51% 64% 0.6 [0.3–1.2] 19% 52% 0.2 [0.04–0.8]c
MN (47) (35) (33) (29)
Never-smokers 27% 26% 1 82% 76% 1
Ever-smokers 73% 74% 1.0 [0.3–2.8] 18% 24% 0.7 [0.2–2.8]
MCN/FSH (54) (46) (45) (42)
Never-smokers 35% 39% 1 67% 62% 1
Ever-smokers 65% 61% 1.5 [0.6–3.7] 33% 38% 0.9 [0.3–2.2]
Abbreviations are: GN, glomerular nephropathy; IgAN, IgA nephropathy; MN, membranous nephropathy; MCN/HSF, minimal change nephropathy or focal
segmental hyalinosis.
aOR, odds ratio adjusted for “age at renal biopsy” and social class; CI, confidence interval
bP , 0.10, cP , 0.05
however, that the cumulative exposure for ex-smokers No relationship was observed between smoking and GN
was higher than that for current smokers (31.5 vs. 24.6 without CRF. Like Orth et al, we found no relationship
PYs). Statistically significant dose-effect relationships between smoking and CRF among women [11]. Al-
were observed between CRF onset and both daily and though the sample sizes in both studies were too small to
cumulative doses of smoking (Table 4). The relationships allow any definitive conclusion about women, the results
were again stronger when cases were compared ac- taken together suggest that an interaction between sex
cording to the presence of CRF than when cases with and smoking exists in their relationship with CRF among
CRF were compared with controls. Adjustment for sol- the GN cases.
vent exposure, a risk factor for GN with CRF in this In men, the relationship with smoking was observed
study [14], did not modify any of these results. for GN as a whole, as well as for two of the three histo-
In men, interactions were observed between age, HT, logic types we studied: IgAN and MCN/FSH. Eight of the
and smoking (Table 5). Below the age of 40 “at renal MN cases with CRF could not be traced for an interview,
biopsy,” smoking was not related to CRF, but they were thereby substantially reducing the power of the data
significantly related for subjects over the age of 40 years. analysis. Nonetheless, all four MN cases with CRF who
When comparing CRF cases with non-CRF cases, with were included smoked, which suggests a trend similar to
a model including age, smoking, and social class, interac- that observed for the other two GN types.
tion between age, and smoking nearly reached statistical Our study was designed to compare GN cases with
significance (P 5 0.07). Likewise, although smoking and (non-GN) controls. To be able to discuss our results with
CRF were not related among the normotensive cases, those of the only available study that considered one of
their relationship was significant among cases with HT, the three primary GN that we studied (IgAN) [11], we
and it remained so after restricting the study to cases in compared cases with CRF with cases without CRF and
which HT occurred before renal biopsy. When HT was
with controls. Although the first two groups were not
added to the model mentioned previously in this article,
matched, potential confounding by age was adequatelyan interaction between HT and smoking was almost sta-
taken into account at the step of data analysis. The rela-tistically significant (P 5 0.08). The highest risk of CRF
tionship observed between smoking and CRF waswas observed among ever-smoking men both older than
stronger when cases with CRF were compared with those40 and hypertensive compared with controls: OR 5 7.6
without CRF than when they were compared with con-(0.9 to 67.0).
trols, mainly for IgAN cases. This might result from
either an overestimation of smoking among controls or
DISCUSSION an underestimation of smoking (or even true underexpo-
sure) among non-CRF cases. Selection bias caused byIn this study, no relationship was observed between
overexposed hospital controls is quite unlikely, sincesmoking and any of the three histologic types considered.
controls with smoking-related disease were excludedA significant relationship, however, was found between
from this analysis, as recommended by Miettinen, for asmoking and CRF in men; it was especially strong for
men older than 40 years and/or hypertensive patients. valid selection of subjects [12].
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Table 3. Relation between smoking and GN according to renal function, by sex and histologic type
Non-CRF cases
CRF cases as compared to
Controls Non-CRF cases
Controls
(N ) % (N ) % ORa [95% CI] (N ) % ORa [95% CI] ORa [95% CI]
All GN, by sex
Men (150) (132) (57)
Never-smokers 35% 45% 1 25% 1 1
Ever-smokers 65% 55% 0.7 [0.4–1.1] 75% 1.7 [0.8–3.5] 2.4 [1.2–4.5]b
Women (92) (88) (17)
Never-smokers 63% 75% 1 76% 1 1
Ever-smokers 37% 25% 0.6 [0.3–1.1] 24% 0.4 [0.1–1.5] 0.8 [0.2–2.9]
By histologic type, in men
IgAN (69) (53) (36)
Ever-smokers 64% 36% 0.3 [0.2–0.7] 72% 1.6 [0.6–3.9] 3.2 [1.1–9.0]b
MN (35) (43) (4)
Ever-smokers 74% 72% 0.7 [0.2–2.1] 100% — —
MCN/FSH (46) (36) (17)
Ever-smokers 61% 60% 1.1 [0.5–2.9] 76% 2.0 [0.6–7.4] 2.3 [0.6–9.5]
Abbreviations are: GN, glomerular nephropathy; CRF, chronic renal failure; IgAN, IgA nephropathy; MN, membranous nephropathy; MCN/HSF, minimal change
nephropathy or focal segmental hyalinosis.
aOR, odds ratio adjusted for “age at CRF or interview” and social class; CI, confidence interval
bP , 0.05
Table 4. Dose-effect relationships between smoking and all GN with CRF, in men
CRF cases compared with
Controls Non-CRF cases CRF cases Controls Non-CRF cases
(150) (132) (57) ORa [95% CI] ORa [95% CI]
Smoking status
Never-smokers 35% 46% 25% 1 1
Ex-smokers 28% 28% 45% 2.3 [1.0–5.2]b 2.8 [1.2–6.4]b
Current smokers 38% 26% 29% 1.1 [0.5–2.6] 2.1 [0.9–4.9]
Lifetime average number of cigarettes/day
0 35% 46% 25% 1 1
#20 41% 44% 45% 1.3 [0.6–2.9] 1.9 [0.9–4.1]
.20 14% 10% 30% 3.0 [1.2–7.5]b 5.2 [2.0–14.0]d
Duration of smoking years
0 35% 46% 25% 1 1
#20 38% 31% 38% 1.5 [0.7–3.3] 2.2 [1.0–4.9]b
.20 27% 23% 36% 1.8 [0.7–4.6] 2.9 [1.1–7.6]b
Number of pack-years
0 36% 48% 26% 1 1
#15 34% 32% 31% 1.4 [0.6–3.2] 1.9 [0.8–4.3]
.15 30% 21% 43% 2.0 [0.9–4.6] 3.9 [1.6–9.5]c
Abbreviations are: GN, glomerular nephropathy; CRF, chronic renal failure.
aOR, odds ratio adjusted for “age at CRF or interview” and social class; CI, confidence interval
bP , 0.05, cP , 0.01, dP , 0.001
By contrast, underestimation of smoking is possible men with isolated hematuria depends on their smoking
status. It may be more likely that the subsequent investi-among GN cases without CRF, since the cases were
selected into study entry on the basis of a biopsy-proven gation of heavy smokers will search for a cancer of the
urinary tract, whereas GN might be considered morediagnosis. Such an inclusion criterion avoids disease mis-
classification, but may induce detection bias by excluding likely for nonsmokers. IgAN might thus be under-detected
among heavy smokers. Although this study cannot pro-GN patients with minimal symptoms, such as isolated
hematuria or low-grade proteinuria. Although we cannot vide evidence of such a phenomenon, its plausibility is
indicated by the limitation of this surprising result todefinitively rule out a protective effect from smoking on
the incidence of IgAN, the unexpected lower than unity IgAN cases, who often present with minimal symptoms.
Such a bias, if present, would only affect the comparisonOR that was observed for those cases without CRF is
more likely to be the consequence of chance or detection of cases with and without CRF within the IgAN group
and, to a lesser extent, in GN as a whole; it would notbias. Indeed, smoking might be indirectly related to the
indications for renal biopsy if diagnostic strategy among alter any of the other comparisons.
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Table 5. Relation between CRF and smoking in men, according to age at renal biopsy and blood pressure
CRF cases as compared to
Controls Non-CRF cases CRF cases Controls Non-CRF cases
(N)% ORa [95% CI] ORa [95% CI]
Age at renal biopsy
#40 years (87) (74) (26)
Ever-smokers 61% 47% 58% 0.9 [0.4–2.3] 1.5 [0.6–3.7]
.40 years (62) (54) (29)
Ever-smokers 71% 63% 90% 3.9 [1.0–15.7]c 5.3 [1.4–20.9]c
Hypertension (HT)
No (128) (87) (6)
Ever-smokers 65% 61% 67% 0.9 [0.2–5.8] 1.1 [0.2–7.0]
Yes (all HT) (21) (41) (48)
Ever-smokers 67% 32% 75% 2.3 [0.6–8.4] 11.1 [3.4–35.7]d
Yes (HT before renal biopsy)b (21) (19)
Ever-smokers 67% 33% 74% 1.6 [0.3–8.1] 6.9 [1.1–43.9]c
a OR, all odds ratios adjusted for social class; OR according to hypertension also adjusted for “age at CRF or interview”; CI, confidence interval
b Comparison of CRF cases with non-CRF cases whose HT occurred before renal biopsy, and with controls with HT
cP , 0.05, dP , 0.001
When we compared cases with and without CRF, we smoking earlier. These findings should be corroborated
by other observations.observed a dose-effect relationship with the number of
Confounding bias is most unlikely since known riskPYs. It was of the same order of magnitude as that
factors of renal disease or CRF were taken into account.observed by Orth et al among men with IgAN and PKD
Men and women were analyzed separately, and age was[11]: OR 5 3.5 and 5.8 for 5 to 15 PY and .15 PY,
carefully taken into account in the regression models.respectively, compared with our findings of 1.9 and 3.9
Solvent exposure was associated with both CRF andfor #15 PY and .15 PY, respectively. Moreover, note
smoking, but taking this variable into account did notthat the percentage of smokers among male controls in
alter any of the observed relationships. Moreover, weOrth’s study (defined as cases of IgAN or PKD without
controlled for social class in order to improve the compa-ESRF) was as low as that among male IgAN cases with-
rability of cases and control recruitment. Indeed, smok-out CRF in ours, that is, 35 and 36%, respectively.
ing is highly correlated to social class, which may alsoAs discussed earlier in this article, the ORs of the
be correlated with a number of behavioral risk factorscomparisons of cases with CRF and those without may
that influence GN incidence or progression.have been overestimated. Indeed, for ever-smokers,
In contrast, we did observe interactions between age,when we compared CRF cases with controls, the OR
HT before CRF, and smoking. Hypertension can be awas lower (51.7), than when we compared them with
cause or a consequence of renal disease, and for thiscases without CRF. Instead, they were close to those
reason, we restricted the study of interaction to cases inpreviously reported among ESRF or type 2 diabetes
which HT preceded renal biopsy taken as a surrogatepatients. In the cohort screened for the Multiple Risk
for GN onset. To our knowledge, interactions between
Factor Intervention Trial, the relative risk of ESRF was
smoking and patients’ characteristics have not been
1.7 for men smoking more than 20 cigarettes per day shown in the renal risks of diabetes patients, except for
(abstract; ibid); in two cohorts of type 2 diabetes patients, acute effects. In a population of a thousand German men
they were equal to 1.5 for current smokers and 2.3 for and women, however, Ho¨rner et al concluded that the
those who smoked more than 40 PY [2, 4]. effect of smoking on the albumin excretion rate was
We would have expected ORs for CRF to be lower more pronounced among hypertensive and diabetic sub-
among former smokers than among current smokers, as jects than among normotensive controls [16]. Likewise,
they are for diabetic nephropathy [1], but they were an interaction with HT has been observed in the relation-
higher. Survival bias is unlikely, since only three of the ship between smoking and renal prognosis in lupus ne-
eligible cases died. Although some irreversible effect of phritis [10].
smoking may explain this result, it may also result from a In the study by Orth et al, a significant interaction was
self-selection phenomenon among patients with a higher observed between smoking and angiotensin-converting
vascular risk, for example, hypertensives and heavy enzyme (ACE) inhibitors: the adjusted (for systolic
smokers. Indeed, in this study, more ex-smokers than blood pressure) OR of ESRF among men associated
current smokers had smoked heavily. Their cumulative with a cumulative dose of smoking greater than five pack-
years was much higher among patients not treated withexposure to tobacco was higher, and they had started
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ACE inhibitors than among those who had been so In conclusion, this study provides additional support
for the hypothesis that smoking has an effect in primarytreated [11]. Unfortunately, we were unable to explore
this type of interaction in our study because only 5% of GN. Smoking appeared to be related to GN severity in
the at-risk group of men whose primary GN arose afterthe cases had been treated with ACE inhibitors, due to
the earlier recruitment period. Taken as a whole, these the age of 40 and/or were hypertensive. These findings,
however, need to be corroborated by further observa-results suggest that a complex relationship exists between
the subjects’ personal characteristics and smoking in the tions in other populations.
severity of GN. Cohort studies of GN patients are needed
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